Position in JBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,651,423
+$18,723,454 QoQ
Shares Held
929,407
+577.3% QoQ
Ownership
1.46%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 153 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JBIO Over Time
Shares Held
Position Value (USD)
Derivatives in JBIO
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
2,300
PutValue
$0
PutShares
4,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. JBIO ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in JBIO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,651,423 | 929,407 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,927,969 | 137,222 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $556,328 | 36,055 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 AVTE | — | 2,300 | Call | Defined | 2025-05-15 | |
| 2025-03-31 AVTE | — | 4,600 | Put | Defined | 2025-05-15 | |
| 2025-03-31 AVTE | — | 31,456 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 AVTE | — | 5,551 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 AVTE | — | 24,300 | Put | Defined | 2025-02-14 | |
| 2024-12-31 AVTE | — | 117,500 | Call | Defined | 2025-02-14 | |
| 2024-09-30 AVTE | — | 900 | Put | Defined | 2024-11-14 | |
| 2024-09-30 AVTE | — | 48,500 | Call | Defined | 2024-11-14 | |
| 2024-06-30 AVTE | — | 30,700 | Put | Defined | 2024-08-14 | |
| 2024-06-30 AVTE | — | 11,100 | Call | Defined | 2024-08-14 | |
| 2023-06-30 AVTE | — | 291,938 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 AVTE | — | 1,561,923 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 AVTE | — | 1,615,578 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 AVTE | — | 1,592,009 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 AVTE | — | 1,593,376 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 AVTE | — | 1,597,479 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 AVTE | — | 1,594,813 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 AVTE | — | 1,614,998 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||